Eli Lilly and Company

Organization

American pharmaceutical company and developer of donanemab for Alzheimer's

13 stories

Researchers Find Boosting Single Protein May Help Brain Fight Alzheimer's Disease

Gene Therapy for Inherited Deafness Shows Sustained Hearing Improvement Over 2.5-Year Follow-Up

GLP-1 Drug Users Report Emotional Blunting, Raising 'Ozempic Personality' Concerns

Study Concludes Anti-Amyloid Alzheimer's Drugs Have No Clinically Meaningful Effect

Study Links GLP-1 Drug Side Effects to Individual Genetic Variations

DeepMind CEO Demis Hassabis Pursues AI-Automated Drug Design

politics47d ago

Trump Imposes Up to 100% Tariff on Brand-Name Drug Imports

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

Researchers Identify 'Death Switch' Mechanism in Alzheimer's Disease

FDA Approves Higher-Dose Wegovy for Weight Loss Treatment

Eli Lilly's Obesity Drug Retatrutide Succeeds in Late-Stage Diabetes Trial

Jensen Huang Envisions AI Transforming Biology Into Engineering Discipline

Two Deaths Reported to Regulators Potentially Linked to Weight-Loss Injections